The implications for Eli Lilly and Novo Nordisk seem pretty clear: The immediate removal of a rival for the massive revenues ...

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Eli Lilly and Novo Nordisk occupy leading positions in the ... As in my article "AbbVie vs. Sanofi: Which Is the Better Investment Right Now", in the table below, I will provide a detailed ...

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer ...

Novo Nordisk offers a pill version of semaglutide, called Rybelsus, for type 2 diabetes, but it requires specific attention to food and water intake. Other companies, such as biotech Viking ...